Nyrada
Menu
NYR:
Market Cap*:
Price Delay ~20min
Home
About Us
Company Overview
Board of Directors
Management
Scientific Advisory Board
Corporate Governance
Investors
Investor Welcome
Company Fact Sheet
ASX Announcements
Neuroprotection Program
Cardioprotection Program
Financial Reports
Corporate Announcements
Investor Presentations
Share Price Information
Key Dates
Investors Glossary
Annual Reports
Analyst Reports
Annual General Meeting
Extraordinary General Meeting
Past Shareholder Meetings
News & Insights
Presentations & Interviews
Media
Newsletters
Publications
Contact Us
Contact Us
Working at Nyrada
Email Alerts
Investors
Home
>
Investors
>
ASX Announcements
>
Corporate Announcements
Investor Welcome
Company Fact Sheet
ASX Announcements
Neuroprotection Program
Cardioprotection Program
Financial Reports
Corporate Announcements
Investor Presentations
Share Price Information
Key Dates
Investors Glossary
Annual Reports
Analyst Reports
Annual General Meeting
Extraordinary General Meeting
Past Shareholder Meetings
Corporate Announcements
Filter by Year:
2024
2023
2022
2021
2020
30-Sep-2024
2024 Annual General Meeting Access Letter, Notice and Proxy
22-Aug-2024
Annual Report for year ended 30 June 2024
27-May-2024
Upcoming Expiry of Unlisted Warrants
16-May-2024
Nyrada General Meeting Results
2-Apr-2024
2024 EGM Letter to Shareholders and Proxy
2-Apr-2024
2024 EGM Notice of Meeting and Proxy
6-Mar-2024
Nyrada Successfully Raises $1.755 Million via Placement
28-Feb-2024
Nyrada CEO James Bonner interview with 180 Markets
19-Jan-2024
Amended and Restated Certificate of Incorporation and Bylaws
1